BRAF, EGFR, KRAS 유전자 분자병리검사에서 DNA 품질에영향을 미치는 병리학적인 인자에 관한 연구
Pathological Factors Affecting DNA Quality in BRAF, EGFR, and KRAS Gene Molecular Tests
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
정확한 분자병리검사를 위해 검체에 대한 질관리의 중요성이강조되고 있다. 본 연구에서 BRAF, EGFR, KRAS 돌연변이 검사에 대해, 검체 종류 및 처리과정 중 DNA 품질에 영향을 미치는 인자를 알아보고자 하였다. 모두 1,772건의 분자병리검사에대해, 검체의 종류, 포르말린 고정시간, 재검기록 등 DNA 품질에 영향을 미칠 수 있는 임상병리학적 요소를 조사하였다. 세포검체는 고정액으로 처리를 한 검체보다 생리식염수에 보관한 검체가 DNA 품질이 좋았다. 조직검체는 10% 중성 포르말린에24시간 이내에 고정된 검체가 그 이상 고정된 검체보다 DNA 품질이 좋았다. 검체 종류 중 신선조직검체, 그리고 종양세포밀도가 높은 조직검체가 파라핀포매조직 및 세침흡인액상 세포검체보다 상대적으로 DNA 품질이 좋았다. 10% 중성 포르말린에24시간 이상 오래 고정된 검체일수록 Non-PNA Ct값이 비례증가하여, 포르말린 고정시간이 검체 DNA 품질에 영향을 준다는 것을 확인하였다. 결론적으로 종양세포의 밀도 및 적절한 포르말린 고정시간이 DNA 품질을 유지하는데 가장 중요한 요소이며, 신속하고 정확한 분자병리진단을 위해 이들 요소를 적절히 관리하여 최적의 DNA 품질을 유지하도록 해야 한다.
Abstract
The quality control of pathological specimens is important for accurate molecular pathology testing. This study evaluated that specimen factors affecting the DNA quality during tissue processing and sample types for BRAF, EGFR, and KRAS mutations tests. One thousand seven hundred and seventy-two molecular pathology tests were investigated for the factors influencing the DNA quality, such as sample type, formalin fixation time, and reexamination status. Cytology samples stored in a saline solution had better DNA quality than commercial cytology preservation. Tissue samples fixed in formalin within 24 hours had better DNA quality than the samples fixed over 24 hours. Between the types of samples, fresh tissue samples and tissue samples with a high tumor cell density had relatively better DNA quality than the formalin-fixed paraffin-embedded (FFPE) tissues and cytology specimens. Of real-time PCR, the non-PNA Ct value increased proportionally with samples held for longer than 24 hours in formalin, and that the formalin-fixed time affects the sample DNA quality. In conclusion, the appropriate tumor cellularity and 10% neutral formalin fixation time are the most important factors for maintaining the DNA quality. These factors should be managed properly for an accurate pathological molecular test to ensure optimal DNA quality.
참고문헌 (10)
- Ian A Cree, "Guidance for laboratories performing molecular pathology for cancer patients", Journal of Clinical Pathology, 67(11), pp.923~931 (2014), BMJ[DOI]
- 2.0.CO;2,
- Latarsha J. Carithers, "The Biospecimen Preanalytical Variables Program: A Multiassay Comparison of Effects of Delay to Fixation and Fixation Duration on Nucleic Acid Quality", Archives of Pathology & Laboratory Medicine, 143(9), pp.1106~1118 (2019), Archives of Pathology and Laboratory Medicine[DOI]
- Hyon-goo Yun, "Factors affecting KRAS mutation detection in colorectal cancer tissue", Pathology - Research and Practice, 215(5), pp.1071~1075 (2019), Elsevier BV[DOI]
- Jingzhu Zhao, "Comparison of diagnostic methods for the detection of a BRAF mutation in papillary thyroid cancer", Oncology Letters, 17, pp.4661~4666 (2019), Spandidos Publications[DOI]
- Yasushi Yatabe, "EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey", Journal of Thoracic Oncology, 10(3), pp.438~445 (2015), Elsevier BV[DOI]
- R. E. Shackelford, "KRAS Testing: A Tool for the Implementation of Personalized Medicine", Genes & Cancer, 3(7-8), pp.459~466 (2012), SAGE Publications[DOI]
- Leah M. Prentice, "Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice", PLOS ONE, 13(4), pp.e0196434~ (2018), Public Library of Science (PLoS)[DOI]
- Mami Taguchi, "DNA identification of formalin-fixed organs is affected by fixation time and type of fixatives: using the AmpFℓSTR ® Identifiler ® PCR Amplification Kit", Medicine, Science and the Law, 52(1), pp.12~16 (2012), SAGE Publications[DOI]
- Jonathan C. Dudley, "Tumor Cellularity as a Quality Assurance Measure for Accurate Clinical Detection of BRAF Mutations in Melanoma", Molecular Diagnosis & Therapy, 18(4), pp.409~418 (2014), Springer Science and Business Media LLC[DOI]